Evidence map›Paper›PMID 28055297›Full record

ArticlemAbs2017

A strategy to identify linker-based modules for the allosteric regulation of antibody-antigen binding affinities of different scFvs.

Sarah-Jane Kellmann, Stefan Dübel, Holger Thie

Abstract read
In one paragraph

Article in mAbs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. "Attack!" Cellular Therapies to Attack Pathogens and Tumors.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2025
    Article
  2. Review
  3. Review
  4. FimH as a scaffold for regulated molecular recognition.Journal of biological engineering · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sarah-Jane Kellmanna Miltenyi Biotec GmbH, Friedrich-Ebert-Straße , Bergisch Gladbach , Germany.
Stefan Dübelb Technische Universität Braunschweig, Institute of Biochemistry, Biotechnology and Bioinformatics , Braunschweig , Germany.
Holger Thiea Miltenyi Biotec GmbH, Friedrich-Ebert-Straße , Bergisch Gladbach , Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody single-chain variable fragments (scFvs) are used in a variety of applications, such as for research, diagnosis and therapy. Essential for these applications is the extraordinary specificity, selectivity and affinity of antibody paratopes, which can also be used for efficient protein purification. However, this use is hampered by the high affinity for the protein to be purified because harsh elution conditions, which may impair folding, integrity or viability of the eluted biomaterials, are typically required. In this study, we developed a strategy to obtain structural elements that provide allosteric modulation of the affinities of different antibody scFvs for their antigen. To identify suitable allosteric modules, a complete set of cyclic permutations of calmodulin variants was generated and tested for modulation of the affinity when substituting the linker between VH and VL. Modulation of affinity induced by addition of different calmodulin-binding peptides at physiologic conditions was demonstrated for 5 of 6 tested scFvs of different specificities and antigens ranging from cell surface proteins to haptens. In addition, a variety of different modulator peptides were tested. Different structural solutions were found in respect of the optimal calmodulin permutation, the optimal peptide and the allosteric effect for scFvs binding to different antigen structures. Significantly, effective linker modules were identified for scFvs with both VH-VL and VL-VH architecture. The results suggest that this approach may offer a rapid, paratope-independent strategy to provide allosteric regulation of affinity for many other antibody scFvs.

Indexed as

Allosteric RegulationAntibody AffinityBinding Sites, AntibodyCalmodulinChromatography, AffinityHumansImmunoglobulin Variable RegionProtein EngineeringSingle-Chain AntibodiesCalmodulinImmunoglobulin Variable RegionSingle-Chain AntibodiesAffinity modulationantibody engineeringantibody fragmentscalmodulin/calmodulin-binding peptide interactioncircular permutationconformational changescFv linker

Identifiers

PMID28055297
PMCPMC5384732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.